logo-loader

Amphion Innovations unit DataTern says it is confident its patents are valid after US court setback

Published: 18:44 02 Nov 2017 AEDT

patent law book
The company will need a new legal team and more cash to fund the patent claim

Amphion Innovations Plc (LON:AMP) said its wholly-owned business DataTern had its US patent infringement case against MicroStrategy and some of its customers dismissed.

The reason for the dismissal was the withdrawal from the case of the firm’s legal counsel and DataTern’s inability to appoint a successor “in the short time frame set by the court”.

WATCH: Amphion Innovations pinning hopes on Polarean Inc after Motif Bio success

Amphion in a stock exchange statement added: “It remains DataTern's considered opinion that the 502 and 402 patents are both valid and being infringed by a wide range of companies that are practicing this critical art. In order to pursue these claims though, DataTern needs to be able to fund the expenses in the programme and efforts to find a suitable funding source and successor legal counsel are continuing.”

Amphion Innovations pinning hopes on Polarean Inc after Motif Bio success

Richard Morgan, chief executive of Amphion PLC (LON:AMP), discusses the 'very welcome' Phase III Iclaprim news from Motif Bio. Motif's recently revealed its lead drug, a next generation antibiotic, successfully negotiated a crucial final-stage clinical study, boosting Amphion’s...

on 10/10/17